Company Profile
TransMedics Stock Price, News & Analysis
- Ticker:
- TMDX
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- United States
Stock performance
80.21 USD (+4.86%)
Close
Last updated: August 6, 2026
2.37B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, TMDX closed up 4.86% at $80.21. No new same-company headline was identified in the current news window.
Company overview
Business overview
TransMedics is a transplant technology company focused on organ transport, preservation, and perfusion systems.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, TransMedics sits in specialized medical devices.
Business Model Characteristics
The company generates revenue through transplant logistics, device usage, and the expansion of its organ-management platform.
Position Within the Biotechnology Landscape
TransMedics is a procedure-driven medtech name whose valuation is tied to adoption in the transplant workflow.
Future catalysts
TransMedics's catalysts are OCS utilization in heart, lung, and liver transplant workflows, plus continued expansion of its organ-network footprint. The market will care about whether the platform keeps winning more procedures and more centers.
Recent news
- 01
TransMedics to Present at Upcoming March Investor Conferences
Source: TransMedics
- 02
- 03
- 04
TransMedics Reports Second Quarter 2020 Financial Results
Source: TransMedics
- 05
TransMedics to Present at the Canaccord 40th Annual Growth Conference
Source: TransMedics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of TransMedics (TMDX)?
TransMedics (TMDX) most recently closed at 80.21 USD, a +4.86% move versus the previous session.
What is the market cap of TransMedics (TMDX)?
TransMedics currently has a market capitalization of 2.37B USD on BioPharmSignal.
What does TransMedics do?
TransMedics is a transplant technology company focused on organ transport, preservation, and perfusion systems.
On which exchange is TMDX stock listed?
TransMedics (TMDX) is associated with NASDAQ, United States, MedTech.
What is TransMedics?
TransMedics's catalysts are OCS utilization in heart, lung, and liver transplant workflows, plus continued expansion of its organ-network footprint.
Which conditions is TransMedics targeting with TransMedics?
TransMedics's catalysts are OCS utilization in heart, lung, and liver transplant workflows, plus continued expansion of its organ-network footprint.
How does TransMedics describe recent progress with TransMedics?
TransMedics's catalysts are OCS utilization in heart, lung, and liver transplant workflows, plus continued expansion of its organ-network footprint.
What future catalysts are investors watching for TransMedics?
TransMedics's catalysts are OCS utilization in heart, lung, and liver transplant workflows, plus continued expansion of its organ-network footprint. The market will care about whether the platform keeps winning more procedures and more centers.